HTN 3 Flashcards
Hypertensive Urgency
Severe elevations in BP (SBP >180 and/or DBP >120) in
otherwise stable pts without target organ damage (TOD).
Symptoms: None or minimal
Cause: Usually related to nonadherence
Goal: Lower BP gradually (hours to days); decreasing BP
too quickly can cause CVA, MI
Things to do
Sit there and wait 5 minutes
Restart or titrate therapy
Pt should follow in 1 week
If there is still the same, then ask if they have symptoms.
Make sure they have taken their medicines.
Symptoms of TIA or heart attack. (difficult breathing, visual call 911)
If someone says they have a headache but not a vision issue they are cleared
Start taking your medication and it will take 2-3 days and weeks
Hypertensive Emergency
Severe elevations in BP (SBP >180 and/or DBP >120) in otherwise stable pts with target organ damage (TOD).
Symptoms: Yes
Goal: Lower BP minutes to hours by no more than 25%, and then lowered to 160/100-110 within the next 2-6 hours
This is only when people feel their blood pressure, there is target organ damage,
There will be headaches and vision changes
There can be drug-induced causes but usually, it is non-adherence.
MAKE SURE DO NOT lower their blood too much that it will be very low. Lower it by 25% and then work on it more
What is Resistant Hypertension
Office B.P above goal and _>3 antihypertensives (if pt is taking 3-4 meds and HTN is not controlled it is resistant HTN.
Risk factors are: older age CKD, black race, DM
Medication adherence, Whitecoat HTN, and POOR blood pressure technique
Risk factors of resitant HTN are
: older age CKD, black race, DM
How to improve resistant HTN?
Removing contributing lifestyle factors are: Obesity, Physical activity, Excessive ETOH, High salt, low fiber diet.
Discontinue interfering substances such as NSAIDS, SYMPATHOMEMATICS, stimulants, Oral contraceptives, Licorice, Ephedra
Optimize current drugs and doses → ARB/ACE AND CCB. If PT is taking HTCZ change to chlorthalidone for better outcomes.
For pt not controlled on 3 drugs consider adding add spironolactone ( aldosteorne antagonist)
pt on resistant HTN and not controlled with three drugs consider
adding spironolactone ( aldosterone antagonist)
Removing contributing lifestyle factors for resistant HTN ARE
Obesity, Physical activity, Excessive ETOH, High salt, low fiber diet.
FOR resistant HTN Discontinue interfering substances such as
NSAIDs, SYMPATHOMEMATICS, stimulants, Oral contraceptives, Licorice, Ephedra.
WHITE COAT HTN
Some patients can get REALLY nervous before their blood pressure is taken. They can have high BP readings taken at the clinic than when taken outside of the clinic.
20/10 INCREASE IN WHITE coat HTN
SOltuon to White coat HTN
24hr Ambulatory BP monitoring (ABPM)
Monitor the blood pressure at home (HBPM or SMBP)
Home blood pressure monitoring provides a “truer” blood pressure reading
Special Populations Race AND Ethnicity
Black pt has a higher prevalence of htn , lower control rates, and higher rates of mortality.
Initial therapy Thiazide-type diuretic or CCB the best choice for single-drug therapy
Most pt will require 2 or more meds to reach the goal → ACE inhibitor or ARB is recommended as an add-on or used when compelling indication.
Special Populations Race AND Ethnicity Initial therapy
Thiazide-type diuretic or CCB (verapamil/diltiazem) the best choice for single-drug therapy
Special Populations Race AND Ethnicity with 2 or more meds
Most pt will require 2 or more meds to reach the goal → ACE inhibitor or ARB is recommended as an add-on or used when compelling indication.
Elderly people with ISH regimens are
Often have ISH Isolated systolic HTN
After age 60 DBP gradually decrease while SBP continues to rise
BP-lowering decreases the risk of fatal and non-fetal stroke and CV events and death
Dihydropyridine CCBs (amlodipine, nifedipine) are effective in older patients with ISH
Elderly people HTN recommendations are
Dihydropyridine CCBs (amlodipine, nifedipine) are effective in older patients with ISH
Elderly people: Treatment can have challengeS THAT ARE
Polypharmacy
Frailty
Cognitive impairment
Variable life expectancy